MAX BERGSTROM: Open Payments
NPI 1104591874 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 17 payments from 6 companies in 2025. Trend: 2023 $1,316 · 2024 $667 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $137 |
| Amgen Inc. | 5 | $94 |
| Novo Nordisk Inc | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: VENCLEXTA, EVENITY, VRAYLAR, OTEZLA, Ozempic, AIRSUPRA, MOUNJARO, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
